GARS1 and breast cancer: The overexpression of nine nuclear MTRGs, including ATAD3, GARS, IARS2, MRPS16, NDUFS1, SUCLA2, ATPAF2, DARS2, and FRDA, significantly related to a worse prognosis of BC patients (p<0.05, Figure 2A).